Jefferies Financial Group Inc. Gilead Sciences, Inc. Put Options Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $2.53 Million - $2.87 Million	34,500 Added 29.14%	152,900 $12.4 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $177,456 - $193,608	2,400 Added 2.07%	118,400 $8.87 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $858,913 - $979,710	11,300 Added 10.79%	116,000 $8.94 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.32 Million - $2.64 Million	30,000 Added 40.16%	104,700 $8.69 Million
Q4 2022 Sep 21, 2023	SELL	$62.32 - $89.47 $2.57 Million - $3.7 Million	-41,300 Reduced 35.6%	74,700 $6.41 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $4.66 Million - $6.68 Million	74,700 New	74,700 $6.41 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.